Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Belinda Lennox has been given the title of Professor of Psychiatry in the 2019 Recognition of Distinction Exercise at the University of Oxford.

Image shows woman smiling at the camera.

Professor Lennox is the first female Professor of Psychiatry at the University of Oxford. She is also an Honorary Consultant Psychiatrist in the Early Intervention in Psychosis (EIP) service for Oxford Health NHS Foundation Trust.

Since joining the Department in 2012, Professor Lennox has led research into the causes and treatment of psychotic illness. Her current research is in the autoimmune basis of psychosis and she jointly runs a clinic with neurologists to assess and treat people with autoimmune psychosis, as well as, running a clinical trial to test out this new approach.

 

I'm so delighted to be given this title and to be the first female professor of psychiatry in the Department of Psychiatry. I'm looking forward to carrying on with my research and improving diagnosis and treatment for those with serious mental illness. I hope that there will be many women joining me soon, as being a clinical academic psychiatrist is certainly the best job in the world!
Professor Belinda Lennox.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Kam Bhui joins MQ Science Council

Professor Kam Bhui appointed to MQ’s Science Council, a group of global experts who guide MQ’s research.

Experts hold first meeting for new international project on depression, anxiety and psychosis

The Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis, or GALENOS project, has launched in central London.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.

Major trials to test effectiveness of cannabidiol on psychosis

Global study involving three clinical trials will investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis or psychotic symptoms, thanks to a multi-million pound grant to Oxford University.

Friendship and mental health in adolescents

Tanya Manchanda's new paper investigates the role of friendship on the mental health outcomes of adolescents

Major wellbeing survey for 9-18 year olds launched

Researchers at Oxford are encouraging schools and colleges in four areas of the country to sign up to be part of the OxWell Student Survey.